AKVA group ASA
AKVA group ASA (AKVA) has acquired 33.7% of the shares in Observe Technologies Ltd (Observe) to further strengthen its digital strategy, as presented at the recent Capital Markets Day.
Observe, through partnership with AKVA, has successfully sold and delivered their artificial intelligence (AI) feeding solutions to more than 20 farm sites in 5 different countries. With this new agreement, AKVA and Observe will continue to develop and leverage their complimentary technologies and solutions using AI to partner with customers to improve fish performance.
Dated: 9 February 2021
AKVA group ASA
Web: www.akvagroup.com
CONTACTS:
Knut Nesse | Chief Executive Officer |
Phone: | +47 51 77 85 00 |
Mobile: | +47 91 37 62 20 |
E-mail: | knesse@akvagroup.com |
Ronny Meinkøhn | Chief Financial Officer |
Phone: | +47 51 77 85 00 |
Mobile: | +47 98 20 67 76 |
E-mail: | rmeinkohn@akvagroup.com |
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Wolters Kluwer N.V.19.9.2025 08:00:00 CEST | Press release
Wolters Kluwer completes capital reduction
Orion Oyj19.9.2025 08:00:00 CEST | Press release
80,802 Orion Corporation A shares converted into B shares
JDE Peet's N.V.19.9.2025 07:55:00 CEST | Press release
Update on intended recommended public offer by KDP for JDE Peet's
Sampo plc19.9.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 18 September 2025
Idorsia Pharmaceuticals Ltd19.9.2025 07:00:00 CEST | Press release
Idorsia’s JERAYGO (aprocitentan) approved in Switzerland for the treatment of resistant hypertension
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom